Pharmaceutical Technology-10-02-2001

Contract Services
Pharmaceutical Technology

October 02, 2001

Recovery of the contract services industry picked up steam in the quarter ending 30 June 2001.

The authors provide a systematic evaluation of the effects of solvent systems, PEG molecular weight, and concentration of CA to PEG on the thermomechanical properties and permeabilities of CA-free films.

Articles
Pharmaceutical Technology

October 02, 2001

Two types of hydrogels used in parenteral protein-delivery systems offer opportunities for achieving a variety of prolonged- and delayed-release patterns.

Columns
Pharmaceutical Technology

October 02, 2001

NIR quality control technology, relatively new to the pharmaceutical industry, could revolutionize processing and packaging.

Columns
Pharmaceutical Technology

October 02, 2001

FDA may adopt new requirements to enhance the safe use of pharmaceuticals and ensure that all US drugs are available when needed.

Part I of this article discusses validation plans, FDA expectations, and specific requirements for the validation of networked systems.

Testing of an in situ fiber-optic transmission probe demonstrates sound hydrodynamic performance and reduced stray-light limitations.

Articles
Pharmaceutical Technology

October 02, 2001

Insulin is one of the most popular proteins to be studied for oral delivery. The authors review the current status of the development strategies of insulin drug delivery systems, the various challenges associated with these systems, and how these challenges may be overcome.

Articles
Pharmaceutical Technology

October 02, 2001

A summary of the conclusions of the PhRMA Workshop on Acceptable Analytical Practices describes equipment qualification practices and guidelines that are designed to help the pharmaceutical industry be consistent in meeting core requirements.

Articles
Pharmaceutical Technology

October 02, 2001

In Part I of this article, the authors summarize the principles of various integrity tests, including their performance and purpose.

Contract Services
Pharmaceutical Technology

October 02, 2001

Evaluating a CRO should involve acquiring feedback from various personnel within the CRO, ranging from executives to line workers.

The author proposes a strategy for achieving a successful partnership with Big Pharma on the basis of forming a relationship with the company, deliberately managing the alliance, and clearly defining roles and responsibilities.